5-Bromo-2-(methylthio)pyrimidin-4(3H)-one

Catalog No.: 
ACBCJS814
CAS No.: 
81560-03-4
Molecular Formula: 
C5H5BrN2OS
Molecular Weight: 
221.08
5-Bromo-2-(methylthio)pyrimidin-4(3H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$154.00In stockInquiry
500g98%$770.00In stockInquiry
1000g98%$1540.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2-(methylthio)pyrimidin-4(3H)-one
IUPAC Name5-bromo-2-(methylthio)pyrimidin-4(3H)-one
MDL No.MFCD00223721
Molecular FormulaC5H5BrN2OS
Molecular Weight221.08
SMILESO=C1NC(SC)=NC=C1Br
InChI KeyBKWWYXOEVKZFDA-UHFFFAOYSA-N
Synonym5-bromo-2-(methylsulfanyl)-3,4-dihydropyrimidin-4-one
CAS No.81560-03-4
PubChem CID240565

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACBCJS814 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXUIV037 route compound structure diagram
    ACXUIV0375751-20-2In Stock
  4. Then
  5. ACBCJS814 route product structure diagram
    ACBCJS81481560-03-4In Stock
Inquiry

2. ACBCJS814 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7In Stock
  4. Plus
  5. ACXUIV037 route compound structure diagram
    ACXUIV0375751-20-2In Stock
  6. Then
  7. ACBCJS814 route product structure diagram
    ACBCJS81481560-03-4In Stock
Inquiry

3. ACBCJS814 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBCJS814 route product structure diagram
    ACBCJS81481560-03-4In Stock
Inquiry

Comments (0)